News & Events

The value of our clients' news is directly related to the macro events and trends shaping the life sciences and healthcare industry. To appreciate one, you must fully understand the other.

Tiberend Strategic Advisors invites those interested in our firm and the companies we represent to access our News Feed and register for our Events Calendar.  Doing so, you will be assured to receive actionable information on the companies and trends that are defining the life sciences and healthcare space.

News Feed

     

Events Calendar

Feb 15 2018

Ehave Enters Blockchain Market for Secure Access of Patient Data in Mental Healthcare and Medical Cannabis

 

Feb 13 2018

KemPharm to Present at the RBC Capital Markets 2018 Global Healthcare Conference

Feb 12 2018

Rebiotix Develops Microbiome Health Index™ to Identify Indicators for Microbiome Restoration

 

Jan 15 2018

Cingulate Therapeutics Presents New Data from its First in Human Proof of Concept Trial of CTX-1301 at the 2018 APSARD Annual Meeting

 

Jan 9 2018

Rebiotix Highlights 2017 Achievements and 2018 Objectives

Jan 9 2018

Cingulate Therapeutics Appoints Experienced Lead Investigator Matthew Brams, MD as Chief Medical Officer

 

Dec 20 2017

Ocugen Expands Focus on Inherited Retinal Disorders by Licensing Novel Modifier Gene Therapy Platform

 

Dec 12 2017

TapImmune Announces Enrollment of First Patient in Phase 2 Clinical Trial for Treating Triple-Negative Breast Cancer Funded by U.S. Department of Defense

Dec 8 2017

Ocugen CEO Dr. Shankar Musunuri Named a 2017 ‘Most Admired CEO’ by the Philadelphia Business Journal

 

Dec 6 2017

TapImmune Appoints Richard Kenney, M.D., F.A.C.P., as Acting Chief Medical Officer

 

Dec 5 2017

CorMedix Inc. Announces Acceptance of Final Post-Marketing Study Data to be Published in the European Journal of Clinical Microbiology and Infectious Diseases

Nov 29 2017

Rebiotix Announces Expansion of Phase 1 Trial of the Company’s Oral Capsule Microbiota Product, RBX7455, Following Successful Completion of Initial Study Arms

 

Nov 21 2017

TapImmune to Present at 29th Annual Piper Jaffray Healthcare Conference

 

Nov 16 2017

KemPharm Completes Successful End-of-Phase 2 Meeting on KP415 with FDA

Nov 9 2017

KemPharm Reports Third Quarter 2017 Results and Provides Corporate Update

View more client news »